Company Filing History:
1 out of 6 
1 out of 19 
1 out of 76 Years Active: 2014-2016
Title: Han Won Cho: Innovator in Pharmaceutical Chemistry
Introduction
Han Won Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyridopyrimidine derivatives. With a total of two patents to his name, Cho's inventions focus on addressing critical health issues.
Latest Patents
Han Won Cho's latest patents include novel substituted pyridopyrimidines, which are represented by a specific formula. These compounds can be utilized as inhibitors of the phosphoinositide 3' OH kinase family (PI3K). The applications of these compounds are extensive, as they can be used for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergies, asthma, and autoimmune disorders. The invention also encompasses pharmaceutically acceptable salts, solvates, polymorphs, esters, tautomers, or prodrugs of these compounds.
Career Highlights
Throughout his career, Han Won Cho has worked with notable organizations such as CMG Pharmaceutical Co., Ltd. and Sungkwang Medical Foundation. His experience in these companies has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Some of his notable coworkers include Gilnam Lee and Chul Soo Lim. Their collaboration has likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Han Won Cho's work in the field of pharmaceutical chemistry showcases his dedication to innovation and improving health outcomes. His contributions through his patents reflect a commitment to addressing significant medical challenges.